Thursday, 1 August 2013

Survey Report: Global And China Blood Product Industry, 2013-2017 Available at MarketResearchReports.biz

Research Report On Global And China Blood Product Industry, 2013-2017
 
Blood products are made by separating and extracting various proteins in plasma and classified into albumin products, immune globulin products, coagulation factor products and other blood products. China enterprises mainly produce nine kinds of products of the first three categories.

To Read The Complete Report with  TOC :


The concentration rate of global blood products is very high and the 5 enterprises of developed countries occupy 8085% of the market. The global plasma volume in 2012 exceeded 30,000 tons and the market scale reached USD 17.5 billion, increasing by 7.4% YOY. The current global blood product market remains relatively stable, mainly driven by emerging economies. 

There are strict regulations and high barriers to entry in China blood product industry. No new blood product manufacturing enterprises are allowed to be further established and the import of most blood product varieties is limited. By July 2013, there are only about 20 blood product manufacturers with normal production in China, with small annual plasma volumes and a low market concentration rate. 

In 2012, China blood product enterprises realized a total plasma volume of 3,300 tons which decreased compared with that in 2011. The major reason was that the plasmacollecting volume of Guizhou Province accounted for nearly 30% of the total volume in China and the shutdown of many plasma stations in the province led to the drop of plasma volume in 2012. 


To Buy a Copy Of This Report:-

As new plasma stations have been gradually put into operation since 2011, the plasma volume is expected to recover in 2013 and gradually reach 3,520 tons in 2011. The plasma volume will start to grow from 2014. In 2012, the market scale of China blood products was CNY 14 billion, increasing by approximately 25% YOY, mainly owing to the rise of product unit price caused by short supply. As the output volume of China blood products falls far behind domestic demand, there is no fierce competition in the market. Most products are sold at prices higher than that in the international market.
 


Contact:-
M/s  Sheela
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-997-4948
Email:        sales@marketresearchreports.biz 

Blog:          http://marketsbuzz.wordpress.com/ 

No comments:

Post a Comment